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Background: Methylmercury (MeHg), known for well over a century as a neurotoxin in adults, has more recently
been studied for potential detrimental effects during early brain development. While several studies have estimated
mercury exposure, they usually rely on either a single biomarker or questionnaire data, each of which has limitations.
The goal of this paper was to develop a toxicokinetic model that incorporates both biomarker and questionnaire data
to estimate the cumulative exposure to MeHg through seafood consumption using data collected from the Childhood
Autism Risks from Genetics and the Environment (CHARGE) study.
Methods: We utilized a previously described discrete-time model that estimates blood MeHg concentration given a
piecewise-constant ingestion rate and single-compartment pharmacokinetics. We measured newborn bloodspot Hg
concentrations and obtained information pertaining to maternal fish consumption using a questionnaire. Using MeHg
concentration estimates from the toxicokinetic model, cumulative MeHg exposure was estimated in children with
autism, children with developmental delay, and typically developing children. Median estimated cumulative MeHg
was compared among diagnostic groups using the Kruskal-Wallis Test. Multinomial logistic regression models were
constructed to assess the association between cumulative MeHg concentration and the risk of autism and developmental
delay (vs. typical development).
Results: The estimated average MeHg concentration of for all fish species consumed by mothers was 42 ppb. Median
cumulative MeHg over gestation was similar across diagnostic groups (p-values raged from 0.91 to 0.98). After adjusting
for potential confounding, we found no association between cumulative MeHg exposure and the risk of autism
(OR = 0.95, 95 % CI: 0.95, 1.12) or developmental delay (OR = 1.00, 95 % CI: 0.89, 1.13).
Conclusions: The toxicokinetic model described in this paper yielded fish MeHg concentration estimates that are
consistent with fish species containing lower levels of MeHg. Overall, cumulative MeHg exposure does not
appear to detectably elevate the risk of autism or developmental delay. Based on the regression standard error
for the association between ASD and TD, we would have reported statistical significance for an adjusted odds
ratio of 1.09 or larger. This method can easily be extended to other epidemiologic studies in which there is a
biomarker measurement and questionnaire data regarding exposure.* Correspondence: sjmckean@ucdavis.edu
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Methylmercury (MeHg) is an environmental contamin-
ant and a known neurotoxin [1]. Concern exists because
the nervous system has been shown to be, at high doses,
especially sensitive to mercury during the prenatal
period [2, 3]. Additionally, because the primary exposure
to MeHg is seafood, low-level exposures are common
[4]. Fetal exposures occur because MeHg readily crosses
the placental barrier [4]. While several studies have mea-
sured biomarker mercury concentrations to estimate ex-
posure, they are often limited by the number and timing
of measurements (typically one sample per participant).
This is especially true when measuring exposure over lon-
ger durations of time (on the order of months or years,
e.g. the entire duration of a pregnancy), without relying on
an unrealistic but common assumption that blood mer-
cury concentrations are at steady-state. In epidemiological
studies, obtaining numerous biological samples over time
is atypical due to the high cost and excessive burden on
study participants. As a result, one biomarker is often
measured, limiting the interpretation to the appropriate
time period the biomarker represents [5, 6]. For example,
one recent study found substantial variability and a poor
correlation (0.19-0.63) for maternal blood mercury con-
centrations across trimesters [6], indicating that a single
blood sample might be inadequate for assessing mercury
exposure throughout pregnancy. Alternatively, food fre-
quency questionnaires are commonly implemented to as-
sess past toxicant exposures, including mercury. To
estimate the ingested dose, this method often relies on
published food toxicant concentration values external to
the study [7]. This approach becomes less reliable when
concentrations vary widely within or across sources of ex-
posure, as is the case with MeHg in populations with ac-
cess to a range of seafood options. Additionally, evidence
suggests that long-term MeHg exposures based solely on
food frequency questionnaires are overestimated, possibly
resulting from the over report of fish consumption and
the utilization of literature-based (versus directly mea-
sured) MeHg concentrations for food items [8–10].
Because biomarker or questionnaire data can limit the
interpretability of the results when used alone, there is in-
creased interest in developing methods that combine these
two types of information in order to gain the advantages
of both. The goal of this paper was to develop a toxicoki-
netic model to estimate the cumulative exposure to MeHg
in children during the gestational period using data col-
lected from the Childhood Autism Risks from Genetics
and the Environment (CHARGE) study. CHARGE is an
ongoing large-scale case–control study focusing on several
genetic and environmental exposures as underlying causes
of autism [11]. We utilized newborn bloodspots collected
shortly after birth (which largely represent third trimester
MeHg exposures) and questionnaire data regarding fishconsumption shortly before and throughout pregnancy.
We incorporated the questionnaire data, blood spot mer-
cury concentrations, and toxicokinetic parameters into a
single model to estimate the average MeHg concentration
of the fish consumed by mothers in our study, effectively
calibrating the exposure model to the measured blood
spot concentrations. Then, using the estimated fish MeHg
concentrations, we estimated the cumulative fetal dose of
MeHg over the gestational period from maternal fish con-
sumption. Estimated cumulative MeHg doses were then




The CHARGE study was initiated in 2002 and is an on-
going population-based case–control study with partici-
pants from three strata: (1) children with autism spectrum
disorder (ASD); (2) children with developmental delay but
not autism (DD); (3) children selected from the general
population without regard to developmental characteris-
tics (GP). Eligible children met the following criteria: (a)
between the ages of 24 and 60 months; (b) living with at
least one biological parent; (c) has a parent who speaks
English or Spanish; (d) born in California; (e) resides in
the study catchment areas of California, including more
than 20 counties within a 2-h drive from the MIND Insti-
tute clinic located at the UC Davis Medical Center in
Sacramento.
Sampling frame and recruitment
Children diagnosed with autism or developmental delay
were identified through the California Department of
Developmental Services (DDS), which, through its sys-
tem of Regional Centers (RCs), coordinates services and
support to individuals with developmental disabilities.
Children with an autism diagnosis who did not enroll in
the RC system were also eligible. The group from the
general population was sampled from California state
birth files. Throughout the study, random samples of
children meeting study eligibility criteria according to in-
formation recorded on the birth certificate were generated.
This group was frequency-matched to the projected age,
gender, and Regional Center catchment area distribution
of autism cases. Study personnel used parents’ names and
social security numbers from the birth files to locate a
current address and phone number for selected GP fam-
ilies. English and Spanish-speaking study personnel made
up to 20 phone calls to contact each selected family and
mailings were also sent.
Diagnostic validation
Trained CHARGE and MIND Institute personnel who
had attained research reliability conducted standardized
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Autism cases were assessed using the Autism Diagnostic
Interview-Revised (ADI-R) [12–14] and the Autism
Diagnostic Observation Schedules-Generic (ADOS-G)
module 1 or 2 [15]. The ADI-R is a standardized, semi-
structured interview administered to the caregiver, and
is designed to assess impairments in reciprocal social
interaction, communication, and repetitive behaviors.
The ADI-R interrater reliability kappa values are be-
tween 0.62 and 0.89 [14]. The ADOS is a standardized,
semistructured assessment of social interaction, and
play or imaginative use of materials. Unlike the ADI-R,
the ADOS requires an examiner to observe the child’s
behavior. Kappa values for interrater reliability are
above 0.60 [16].
Cognitive function was measured in all children using
the Mullen Scales of Early Learning (MSEL) [17]. Adaptive
function was assessed by parental interview using the
Vineland Adaptive Behavior Scales [18]. The evaluation
for the DD and GP children was completed with the same
protocol as children with autism, minus the ADI-R and
ADOS. All controls (DD and GP) were screened for aut-
ism spectrum disorders using the Social Communication
Questionnaire (SCQ) [19]. If the SCQ score was >15, the
ADI-R and ADOS were then used to evaluate for ASDs.
Final autism case status (ASD) was defined as : 1. meeting
criteria on the communication, social interaction, and re-
petitive behaviors domains of the ADI-R and scoring at or
above the total cut off for autistic disorder on the ADOS
module 1 or 2 ; 2. children who met the criteria on either
the communication or repetitive behavior domains of the
ADI-R, were within 2 points of meeting the criteria on the
other domain, and met the requirements for ASD on the
social and communication domains of the ADOS. The
DD group is comprised of children who obtained an
MSEL score of < 69 and a VABS composite score of < 70.
Children from the general population who were not DD
or AU were identified as typically developing (TD) if they
scored: (1) 71 or above on Mullen, (2) 71 or above on
Vineland and (3) <15 on SCQ. Children who were scored
as typically developing according to our validation but en-
tered the study with a diagnosis of ASD or DD were classi-
fied as atypically developing (AtD) and were combined
with the DD group for the purposes of this study.
Data collection
Exposure assessment and other variables
Trained bilingual and bicultural (English and Spanish)
interviewers asked the primary caregiver questions over
the telephone regarding peri-conceptional, prenatal, and
early childhood exposures and experiences. The interview
included questions about maternal fish consumption during
three, two, and one month prior to pregnancy, and during
each trimester. Questions distinguished among tuna (freshor canned), other ocean fish, freshwater fish, and fish
caught by the participant or by someone they knew. If the
participant or someone they knew caught the fish, they
were asked to specify the exact type, and we categorized it
as tuna, other ocean, or fresh water. One serving of tuna
was defined as 3 ounces of fresh tuna, one half can, or one
fish sandwich. For each fish category, we asked about fre-
quency of servings per week, categorized as: 0 (none),
greater than zero but less than one, one, and more than
one. The caretaker was provided with a list of fish species
and which category they fell under. Other covariate infor-
mation was collected including maternal and paternal edu-
cation, maternal age, and ethnicity. Gestational age of the
child was abstracted from medical records.
Bloodspot collection and laboratory analysis
Bloodspots collected at birth for newborn screening
were obtained from California state archives. The blood
samples were analyzed blindly with respect to group.
Total blood mercury was measured at the UC Davis In-
ductively Coupled Plasma-Mass Spectrometry (ICP-MS)
(Agilent Technologies, Santa Clara, CA) Center (icpm-
s.ucdavis.edu) using laser ablation with a 213 nm laser
(New Wave) equipped with a SuperCell to improve Hg
performance-both washout and signal strength. Blood
spot samples and five standards were mounted on steril-
ized glass slides with double-sided adhesive tape and
loaded into the laser chamber with standards prepared
from clinical laboratory reference blood (Wadsworth
Center, Albany, NY). For each blood spot, measurements
were taken on one line scan (0.5 mm long). New Wave’s
software program GLITTER was used to analyze the
bloodspot mercury data. Measurements were in parts
per billion, with a detection limit of 0.01 ppb. Values
were imputed for bloodspot reading below the limit of
detection by dividing the limit of detection by the square
root of two.
Data analysis and statistical procedures
Preliminary analyses
We examined the univariate distribution of the natural
log bloodspot Hg concentration to ensure that the levels
measured in our study are consistent with the previously
reported values, bearing in mind that newborn blood Hg
concentrations are higher than maternal blood Hg con-
centrations. Additionally, we constructed a linear regres-
sion model to verify whether fish consumption (summed
across fish types) during the third trimester predicted
bloodspot Hg concentration.
Pharmacokinetic models
We utilized a previously described discrete-time model
[20, 21] that estimates blood MeHg concentration given a
piecewise-constant ingestion rate and single-compartment
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shown to adequately represent the accumulation and ex-
cretion of MeHg in humans [1]. In our study, we mea-
sured the blood Hg concentrations in the bloodspots and
the time-varying rate of fish consumption from the ques-
tionnaire, and from this information, we wish to estimate
the average mercury concentration of the fish consumed
by the mothers during and just prior to pregnancy in our
study. Blood mercury concentrations CB (micrograms per












where Ij is the fish intake rate (Kg/day) during time period
j, c is the fish MeHg concentration, f is the fraction of
ingested MeHg remaining in the blood after it is absorbed
across the gastrointestinal tract and distributed through-
out the body, k is the first-order rate constant for MeHg
elimination (day−1), and Vi,j is individual blood volume (in
liters) during each time period. We assume that fish mer-
cury concentration is constant over time.
The equation above can be rewritten to show that
blood MeHg concentration is a function of the constants
(f, k, V) and the time weighted fish consumption rate
and the fish MeHg concentration c:
CB tq
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where the weighted average of the time-varying fish con-





and the weights (accounting for the elimination of mer-
cury from the blood over time) during each time step
are given by:




Fish consumption occurring further away in time prior
to bloodspot collection carries less weight while fish
consumption that occurred closer to bloodspot collec-
tion (e.g. the third trimester) carries more weight in
terms of predicting bloodspot mercury concentration.
Mercury exposures prior to 3 months preconception are
assumed to have a negligible contribution to blood mer-
cury concentrations at birth. Notably, the blood mercury
concentration is expected to be a linear function of the
fish mercury concentration. Background (non-fish) mer-
cury exposures should constitute an additive contributionif those exposures are constant over time. Thus, the fish
mercury concentration can be estimated using ordinary
linear regression if the other parameters are known (with
fish MeHg concentration acting as the estimated beta co-
efficient, f Ī/kV as the “covariate”, and the background
MeHg contribution as the intercept).
We developed several models to estimate average fish
concentration. First, we predicted the fish concentration
separately for each category of fish in the CHARGE
questionnaire (Tuna, Other Ocean, and Freshwater).
Fish that was caught, when possible, was categorized
into one of the three fish types. Two mothers ate un-
identified caught fish types, and were excluded. Fre-
quency of consumption during each time period (Ij) was
assigned the following values: 0 (none); 0.5 (more than 0
but less than 1 serving per week); 1 (1 serving per week);
2 (>1 serving per week). We also ran the regression
model described above with the fish consumption rates
summed across fish type, and assigned continuous
values to the following categories: 0 (none), (1) between
0 and 2 servings, (3) 2 or more servings. To make the
units consistent, servings per week were converted to
Kg/day. We assumed an average serving size to be 6 oz
or 0.17 Kg.
Time steps (tj, in days) were assigned based on time pe-
riods covered by the CHARGE questionnaire, with intervals
of: −90 to −60 days (3 months preconception), −60
to −30 days (2 months preconception), −30 to 0 days
(one month preconception), 0 to 90 days (1st trimester),
90–180 days (2nd trimester), and 180 days until birth
(3rd trimester, using the recorded gestational age at
birth for each child). For children born before the be-
ginning of the 3rd trimester, the gestational age at birth
was used to determine the upper limit for the interval
associated with the 2nd trimester. The MeHg elimin-
ation rate, k, was assumed to be 0.014 day-1 based on
the mean value obtained in a controlled dosing study
[22]. The fraction (f ) of MeHg remaining in blood after
absorption and distribution is approximately 0.05 [22].
Individual blood volume was estimated from maternal
weight data during each time period. For some mothers,
weight information was available from both medical re-
cords and through self-report, while others only had
weight information from one of the sources of informa-
tion. We assigned the mother’s weights for each time
period based on a scheme that favored medical record
data when available. For prepregnancy time periods, we
assigned the medical record prepregnancy weights if
they were available (52 %). If they were not available, then
we assigned the self-reported values from the EEQ. For
first trimester weight, we assigned the weights from the
medical records for the first prenatal visit if the first pre-
natal visit occurred during the first trimester (gestational
age ≤12 weeks). If the medical record was not available or
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assigned the medical record prepregnancy weight or the
reported prepregnancy weight (depending on availability).
For the majority of mothers, the weight is similar between
the two time periods (often the same or elevated a few lbs
in the first trimester versus prepregnancy). This is typical
during most pregnancies [23]. For the third trimester, we
assigned the medical record weight during the last pre-
natal visit, if this occurred during the third trimester. If
this was not available, we assigned the medical record
weight during the admission for delivery if admission was
during the third trimester (there are only a few instances
where admission weight is available, but last prenatal visit
is not). If no medical record data was available for third
trimester weight, then the prepregnancy weight plus the
self-reported weight gain during pregnancy was used. In
the few cases where child delivery occurred prior to the
third trimester, the weight was assigned to the second tri-
mester. Because we do not have data for second trimester
weights, we assigned the first trimester weight plus half of
the weight gained during pregnancy. These values can be
reasonably interpolated in this way because weight gain is
fairly linear between the first and the third trimester [23].
Blood volume was determined from maternal weight
using two methods. In the first method, volume was
converted from maternal weight in kilograms to blood
volume in using previously estimated conversion factors.
For the prepregnancy periods and the first trimester, we
used 0.065 L/Kg [24]. Conversion factors during preg-
nancy range from 0.073 to 0.096 L/Kg [25]; we used
0.080 L/Kg for the second and third trimesters. The sec-
ond method to assign blood volume relied on the in-
crease in weight during pregnancy rather than absolute
weight during each time period. Because there is no ex-
pected weight gain during the prepregnancy period and
very little, if any, during the first trimester, we again
assigned 0.065 L of blood per kilogram of body weight.
For the second trimester and third trimesters, we as-
sumed blood accounted for 15 % and 20 % of the total
weight gained over pregnancy, respectively [23]. The
proportion of weight attributed to blood was converted
to liters by dividing the weight of blood (Kg) by the
density of blood, which is about 1.06 Kg/L [26]. These
values for the second and third trimesters were added to
the calculated prepregnancy blood volume, resulting in es-
timates for the second and third trimester blood volumes.
A description and the source of data for the model para-
meters are summarized in Table 1.
We performed analyses assuming newborn blood spot
MeHg concentrations were equivalent to maternal blood
MeHg concentrations at the time of birth, and repeated
the analyses assuming bloodspots had concentrations 1.5
and 2 times the concentration of the corresponding
mother. The ratio of 1.5 and 2 were selected based onpreviously reported values suggesting that the mercury
concentration in cord blood is higher than that of the
corresponding mother [27, 28]. We excluded 161 mother-
child pairs with missing information pertaining to fish con-
sumption of any type during any time period, leaving 296
mother-child pairs. We further excluded 9 mother-child
pairs with missing gestational age data and 13 mother-child
pairs with missing maternal weight, leaving a final sample
size of 274 mother-child pairs for these analyses.
To estimate cumulative dose during the gestational
period, we used the combined fish types MeHg concentra-
tion estimate and computed the area under exposure-time
curve for each trimester by integrating the pharmacoki-
netic model with respect to time from conception up until
the day of bloodspot collection, tq, and summing the cu-
mulative exposure for each trimester to get the cumulative
gestational exposure. We also estimated the cumulative
exposure over the 2nd and 3rd trimester combined. Cu-
mulative exposure was estimated among the ASD, DD/
AtD, and TD groups and the medians were compared
using the Kruskal-Wallis Test (due to the non-normal dis-
tributions). We also constructed multinomial logistic re-
gression models to look at the association between natural
log cumulative MeHg concentration and the risk of ASD
and DD (vs. TD). Because values of MeHg concentration
included 0, we added 0.5 to all cumulative concentrations
prior to taking the natural log. We investigated if the
associations were confounded by gender, maternal age
(centered at the mean), maternal education, maternal
birthplace, child’s race/ethnicity, and payment method for
child delivery. We considered a covariate a confounder if
it changed the OR for Autism associated with a one unit
increase in cumulative mercury on the natural log scale by
10 % or more upon its removal from the model.
Results
The ASD and TD groups were similar with respect to
maternal education, maternal age, child’s race ethnicity,
and payment method for child delivery. The ASD group
had a higher proportion of males than the DD/AtD and
TD groups. As compared with the ASD and TD groups,
the DD/AtD group had fewer mothers with a bachelor’s
or graduate/professional degree, more mothers born in
Mexico, more Latino children, and a higher proportion
of deliveries covered by public health insurance (Table 2).
The general characteristics were similar between the full
data set and the subset with complete fish consumption
data. The bloodspot mercury concentration distributions
were similar among all diagnostic groups (Table 3).
The estimated MeHg concentration for tuna, other
ocean fish, and fresh fish were 5 (95 % CI: −65,75), 50
(95 % CI: 8,91) and 39 (95 % CI: −29, 106) ppb, respect-
ively. The estimated MeHg concentrations for the com-
bined fish types were similar between the two methods
Table 3 Distribution of bloodspot Hg concentrations (ppb) by
developmental group
ASD DD/AtD TD
N 164 35 58
Range 0.07, 40.65 0.90, 15.84 0.18, 22.63
Mean 4.73 4.29 4.73
Median 3.41 3.49 3.48
Geometric Mean 3.34 3.24 3.67
(95 % C.I.) (2.97, 3.84) (2.50, 4.19) (3.02, 4.46)
Table 1 Description and source of data for the model
parameters
Data on mother-child pairs from the CHARGE study Symbol Units
Bloodspot Hg concentration CB ppb
Maternal fish consumption
Rate during each time step Ij Kg⋅day
−1
Time steps tj days
Gestational age at birth tq days
Blood volume Vj L
Assumed parameters
Fraction of MeHg in blooda f -
MeHg elimination Rateb k day−1
Estimated parameter
Fish concentration c ppb
aSherlock et al., [22]
bWHO, [1]
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we assumed that maternal newborn blood mercury con-
centrations were 1.5 times that of the corresponding
mothers, the estimated fish concentration was 42 ppb
(95 % C.I. 12, 72) when blood volume was based on ab-
solute maternal weight, and 47 ppb (95 % C.I. 15, 78)Table 2 General characteristics of each developmental group
ASD DD/AtD TD
Number 164 35 58
Gender, n (%)
Males 149 (91 %) 22 (63 %) 46 (79 %)
Females 15 (9 %) 13 (37 %) 12 (21 %)
Maternal education, n (%)
Less than High School or
High School
Degree 24 (15 %) 11 (31 %) 15 (26 %)
Some College or Vocational School 68 (41 %) 14 (43 %) 12 (21 %)
Bachelor’s Degree or
Graduate/Professional Degree 72 (44 %) 23 (26 %) 31 (53 %)
Average maternal age (years) 31 30 31
Birth place of mother, n (%)
USA 124 (75 %) 23 (66 %) 44 (76 %)
Outside USA 40 (25 %) 12 (34 %) 14 (24 %)
Child’s race/ethnicity
White (non-Latino) 78 (47 %) 11 (31 %) 25 (43 %)
Latino 52 (32 %) 17 (49 %) 22 (38 %)
Other 34 (21 %) 7 (20 %) 11 (19 %)
Payment method for delivery, n (%)
Public 31 (19 %) 12 (34 %) 9 (16 %)
Private 133 (81 %) 23 (66 %) 49 (84 %)when blood volume was based on maternal weight gain.
Changing the elimination rate by 2 standard deviations
leads to about a 10 ppb change in the fish MeHg con-
centration estimate. The estimated fish MeHg concen-
tration is directly proportional to the ratio between
maternal and newborn MeHg concentrations (Fig. 1).
Due to incomplete diagnoses, 36 of the 274 mother-
child pairs with complete fish consumption data were
excluded from analyses comparing cumulative MeHg ex-
posure among diagnostic groups. The cumulative MeHg
distributions over the entire gestational period and over
the 2nd and 3rd trimesters, computed using the com-
bined fish types MeHg concentration estimate of 42 ppb,
were similar among the three diagnostic groups (Table 4,
Fig. 2). The method of assigning blood volume from ma-
ternal weight gain resulted in higher cumulative MeHg
concentrations versus the method based on absolute
weight. Using the Kruskal-Wallis Test, we found that the
median cumulative MeHg concentrations were not sig-
nificantly different among the three diagnostic groups
for all measurements of MeHg AUC (p-value raged form
0.91 to 0.98, depending on the comparison). The multi-
nomial logistic regression models yielded null ORs for
log cumulative MeHg exposure over the gestational
period for ASD vs. TD and DD/AtD vs. TD (Table 5).
Models investigating cumulative exposure over the 2nd
and 3rd trimesters yielded almost identical results (not
shown).
Discussion
Our goal was to relate the longitudinal maternally-
reported fish intake to the measured concentration of
Hg in the neonate’s blood at the time of delivery in order
to estimate the average MeHg concentration in fish con-
sumed by mothers, and to estimate the cumulative fetal
exposure to MeHg. We found that the ASD, DD/AtD,
and TD groups did not have significantly different esti-
mated cumulative mercury distributions, both through-
out pregnancy and over the 2nd and 3rd trimester. Our
multinomial logistic regression models, adjusted for po-
tentially confounding demographic characteristics, yielded
null associations between natural log cumulative MeHg
exposure and the risk of autism (vs. typical development)
Fig. 1 The effect of varying the elimination rate of MeHg from the blood and the assumed relationship between newborn blood MeHg and
maternal blood MeHg concentration
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results do not suggest an association between prenatal cu-
mulative MeHg exposure and the risk of autism or devel-
opmental delay.
This is the first investigation of the association between
prenatal cumulative MeHg exposure and autism. While
several studies have investigated the association betweenTable 4 Pharmacokinetic model-based estimate for cumulative
MeHg exposure by diagnostic group
Area under the curve (ppb)
2nd and 3rd trimesters Gestational period
ASD DD/AtD TD ASD DD/AtD TD
Number 153 32 53 153 32 53
Method 1a
Median 133 140 140 219 262 203
95th % 428 360 408 693 580 680
Range 0 - 545 0 - 378 0 - 443 0 - 1231 0 - 654 0 - 702
Method 2b
Median 144 149 152 241 286 218
95th % 438 388 407 732 680 688
Range 0 - 1395 0 - 487 0 - 523 0 - 1703 0 - 713 0 - 800
aMethod 1 converts individual maternal body weight to volume of blood
based on weight during each time period
bMethod 2 converts individual maternal body weight to volume of blood
based on weight gain during pregnancymercury and autism, they have mostly focused on the
postnatal and post-diagnostic period [29–33], which limits
any discussion of etiology. In contrast, this study estimates
exposures that predated the autism diagnoses and that oc-
curred during the period of time when the developing
brain is most sensitive to MeHg exposure. This study has
several additional advantages. Because we had bloodspot
biomarkers and data regarding fish consumption during
pregnancy, we were able to estimate the average MeHg
concentration of fish consumed by mothers in our study,
without assuming that maternal blood MeHg concentra-
tions were stable during pregnancy, or relying on exter-
nally published, and potentially inappropriate, fish MeHg
concentrations. Additionally we were able to use
individual-level data on gestational age and maternal
weight (converted to blood volume) to refine the pharma-
cokinetic model and AUC estimates in order to better
classify participants according to estimated prenatal MeHg
exposures. We were also able to make comparisons
between groups of individuals who have confirmed diag-
noses based on standardized psychometric evaluations.
While we did not find an association between cumulative
mercury exposure and autism, there is evidence suggesting
mercury still might have a negative impact on cognitive
development; future research should investigate the pos-
sible association between cumulative prenatal mercury ex-
posure and measures of cognitive development.
Fig. 2 Distribution of cumulative prenatal MeHg exposure in each diagnostic group. All groups have similar distributions, with insignificantly
different median concentrations (p = 0.92)
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of cumulative exposure is desired, but only a single bio-
marker measurement is available. While cumulative ex-
posure can be estimated from a food questionnaire
alone, this typically utilizes concentrations for various
foods reported by sources external to the study, and may
not be comparable to the concentrations in the food
consumed by the study population. Instead of relying
on externally reported concentrations estimates, the
method presented in this paper estimated dose by relat-
ing maternally-reported fish consumption to measured
blood concentrations. This is especially pertinent to
our study population because in 2001, the FDA beganTable 5 Association between natural log cumulative prenatal mercu
(vs. Typical Development)a
Unadjusted
Log MeHg AUC O.R. (95 % C.I.) p-val
ASD 1.01 0.72
(vs. TD) (0.94, 1.10)
DD/AtD 1.02 0.70
(vs. TD) (0.91, 1.14)
*Adjusted for: Gender, maternal education, child’s race, maternal birth place, matern
aSample Sizes: Au/ASD = 153, DD/AtD = 32, TD = 53advising women of childbearing age who may become
pregnant to avoid eating fish species high in mercury.
By essentially calibrating the fish concentrations to the
observed biomarker data, the accuracy of the dose esti-
mates may be improved compared to methods relying
solely on external concentration estimates. Addition-
ally, MeHg exposures based solely on food frequency
questionnaires are overestimated, possibly resulting
from the over report of fish consumption [8–10]. If fish
consumption was over reported, then our fish mercury
concentrations would tend to be underestimated to a
similar degree, because the resulting cumulative expos-
ure estimates are calibrated to the observed blood spotry exposure and the risk of autism and developmental delay
Fully adjusted*





al age, and payment method for child delivery
Table 6 Examples of fish with lower levels of mercury [34].
ND =Mercury concentration below detection level (Level of
Detection = 10 ppb)
Species Mercury concentration (ppb)
Mean Median Std. Dev.
Anchovies 17 14 15
Catfish 25 5 57
Pollock 31 3 89
Salmon (canned) 8 ND 17
Salmon (Fresh/Frozen) 22 15 34
Sardine 13 10 15
Tilapia 13 4 23
Trout (freshwater) 71 25 141
Tuna (canned light) 128 78 135
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ways in which our method has advantages over using
questionnaire data alone; when estimating cumulative
fish concentrations, a systematic tendency to over report
fish consumption is counteracted by a reduction in the es-
timated MeHg dose per serving.
Like most statistical models, our approach relies on
some simplifying assumptions. For example, we estimate
only a single MeHg fish concentration per fish type, des-
pite that fact that MeHg concentrations can vary widely
even within the same species of fish [34]. Our linear re-
gression models estimate the MeHg fish concentration
averaged over different participants in a study. We also
assume that the pharmacokinetic parameters do not vary
across individuals. For example, we were unable to reason-
ably estimate the ratio for maternal blood mercury con-
centration versus newborn blood mercury concentration
for each specific mother-child pair; instead, we assumed
an average ratio and used this value for all mother-child
pairs. This reduces the predictive ability of the model
(depending on how much the ratios vary around our
assumed average ratio). Additionally, we assume that
average fish concentration does not depend on the time
period, enabling estimates of overall average fish con-
centration versus having to estimate multiple time-
specific concentration estimates.
Our measurements in blood spots were total mercury,
which is comprised of both inorganic and organic mer-
cury [4]. Because our concentration estimates are based
on the estimated average change in total mercury blood
mercury concentration per serving of fish, these esti-
mates will not be influenced by the inorganic compo-
nent of mercury unless there is a relationship between
fish consumption and inorganic mercury exposure. This
assumption is reasonable because the mercury in fish is
mainly methylmercury (about 90 %) and the ingested in-
organic fraction is poorly absorbed across the intestinal
tract [35]. Furthermore, in a controlled dosing study,
Sherlock et al. found that the inorganic fraction of total
mercury in blood was less than 5 % [22]. To ensure that
dental amalgams (a source of Hg vapor that readily en-
ters the bloodstream) [4] did not confound our esti-
mated fish concentration, we controlled for the number
of maternal dental amalgams at the beginning of preg-
nancy. Maternal dental amalgams weakly predicted
about a 0.5 ppb (p = 0.25) increase in blood mercury con-
centration, and minimally affected the fish concentration
estimate. This strengthens our assumption that the organic
mercury concentration estimated in the regression model is
not influenced by exposures to inorganic mercury.
Although we had initially planned to use the model to
estimate separate mercury concentrations for the indi-
vidual types of fish, those estimates appeared unreliable.
According to the FDA, median tuna MeHg concentrationsrange from 78 to 560 ppb, depending on the species of
tuna [34]. Even if we assume a majority of pregnant
mothers avoided species high in MeHg, we would expect
our tuna concentration estimate to hover around 78 ppb,
which is significantly higher than our estimate of 5 ppb.
When tuna alone was included in the regression model,
the estimated tuna MeHg concentration was 44 ppb. Add-
ing the other types of fish to the model decree.sed the esti-
mated tuna MeHg concentration to 5 ppb. Because the
consumption of tuna is associated with the consumption
of other types of fish, the other fish types may have sub-
sumed the contribution that tuna has to blood MeHg
concentration when they are included in the model.
Additional error could stem from the imprecision asso-
ciated with recalling specific types and quantities of
fish.
As described in the methods, we instead summed the
self-reported fish consumption rates across fish types
(tuna, other ocean, freshwater). Using a single consump-
tion rate for all fish may reduce the effects of impreci-
sion and potential confounding compared to the analysis
using individual fish types. The estimated average fish
MeHg concentration for the analysis using combined
fish types was 42 ppb, assuming an elimination rate of
0.014 and a ratio of 1.5 between newborn and maternal
blood. This estimate is well within the range of MeHg
concentrations measured in commercially available fish
that are lower in mercury including: catfish, cod, salmon,
tilapia, trout, and canned light tuna (Table 6). Our esti-
mated concentration of 42 ppb is lower than the median
concentration for canned light tuna (78 ppb; sd = 135 ppb)
but higher than that for other popular fish types such as
salmon, cod, and tilapia. Our estimated MeHg concentra-
tion is also lower than the average concentration in the
U.S. fish diet estimated by Groth (86 ppb) [36]; however,
there is reason to suspect the distribution of the fish
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of the overall U.S. population. It is a plausible average fish
MeHg concentration if mothers in our study followed
guidelines and primarily consumed species with low mer-
cury levels. Indeed, a recent study of pregnant women in
the Boston area reported "intake of tuna fish in particular
decreased from before pregnancy," though there was con-
fusion among some participants about which seafood spe-
cies are safer to consume during pregnancy [36].
Although estimating the mercury concentration for all
fish types combined mitigated error resulting from im-
perfect recall of specific fish types, the reliability of this
method is still dependent on having useful exposure
questionnaire responses regarding the quantity of fish
consumed, which are more difficult to obtain as ques-
tions address behaviors further back in time. For ex-
ample, women in our study may not have been able to
accurately recall their fish consumption rates in early
pregnancy or prior to pregnancy. The use of pharmaco-
kinetic weights ensures that the calibration is most heav-
ily influenced by recent exposure behaviors, but even
those are measured imprecisely using questionnaires. In
some settings errors in dietary recall could be worse
than the repeat reliability of a biomarker, in which case
our methods might harm rather than improve the accur-
acy of exposure assignment compared to using a single
biomarker alone. We suspected that might be the case
for our analysis based on separate consumption rates for
different fish types, which is why we combined the fish
types for our final model. Future studies using pharma-
cokinetic calibration could also employ Bayesian tech-
niques [37] to account for uncertainties in self-reported
exposure behaviors, rather than treating them as fixed
covariates as we have done here.
To estimate the average MeHg concentration in fish
consumed by mothers during pregnancy, we relied on
various pharmacokinetic parameters estimated in previ-
ous studies. These included the elimination rate of
MeHg from the blood, the fraction of ingested mercury
present in the blood after absorption across the gastro-
intestinal tract and distribution throughout the body,
and the ratio of MeHg concentration between maternal
and newborn blood. While the assumed values of the es-
timated pharmacokinetic parameters among our study
participants likely differ from the true values, we were able
to adjust parameters in our models to assess the impact of
these assumptions on the estimated MeHg concentration.
We found that a dramatic increase (2 standard deviations)
in the elimination rate only increased the fish concentra-
tion estimate by about 10 ppb. The ratio between maternal
and newborn blood MeHg concentration was proportional
to the estimated fish MeHg concentration. The variations
in our fish MeHg concentration (about 25 to 75 ppb) cor-
respond to fish species that are low in MeHg.We measured the Area Under the Curve (AUC) of
MeHg exposure over the pregnancy period and over the
2nd and 3rd trimesters. This metric was chosen to deter-
mine if increasing exposure to MeHg over time is associ-
ated with autism. We used the MeHg concentration of
the combined fish, 42 ppb, because the estimates pro-
duced in this model were robust to varying model as-
sumptions and could be supported by published fish
concentrations.
This method can easily be extended to other epidemi-
ologic studies in which there is a biomarker measure-
ment and reliable questionnaire data regarding exposure,
given that the single-compartment model is reasonable
and that pharmacokinetic parameter estimates are avail-
able. While the questionnaire allowed us to estimate the
average overall fish MeHg concentration, we could not
accurately estimate the concentration for the individual
fish types, which may have resulted in more specific in-
dividual cumulative dose estimates. Although combining
the fish types into a broader category blends the individ-
ual concentrations together, this may not lead to a sub-
stantial amount of misclassification because the MeHg
concentrations vary widely from one fish to the next
within a fish type and the levels also overlap extensively
among the different fish types, with coefficients of vari-
ation often exceeding 100 % (Table 6). Studies utilizing
this method may benefit from grouping sources of ex-
posure that have similar concentration distributions, and
if possible, into categories that are not correlated with
one another. Categories based on externally reported
MeHg concentration could also provide a way to validate
the model estimates, as the estimated MeHg concentra-
tion would be expected to increase across categories
with increasingly higher MeHg concentrations, e.g. sal-
mon versus tuna. In cases where there is only one source
of exposure, the estimated concentration estimate could
be compared to the expected concentration (based on
externally reported values) as a way to validate the re-
ported level of exposure. Assuming externally reported
values are accurate and the model assumptions are rea-
sonable, lower than expected concentration estimates
would suggest a tendency to over report exposures,
while higher than expected concentrations would sug-
gest underreporting.
Conclusions
The toxicokinetic model described in this paper yielded fish
MeHg concentration estimates that are consistent with fish
species containing lower levels of MeHg. Overall, cumula-
tive MeHg exposure does not appear to elevate the risk of
autism or developmental delay. Although the model esti-
mating seafood mercury concentrations relies on several
simplifying assumptions and can be prone to error resulting
from imperfect recall of seafood consumption, it may have
McKean et al. Environmental Health  (2015) 14:62 Page 11 of 12advantages over the use of either single time-point bio-
markers or self-reported dietary data alone. This method
can easily be extended to other epidemiologic studies in
which there is a biomarker measurement and questionnaire
data regarding exposure.
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